Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9660132 | 0.87 | ALDH1A1 (0.33) | — | |
| SCHEMBL1434776 | 0.76 | — | — | |
| SCHEMBL6173406 | 0.74 | — | — | |
| SCHEMBL11963724 | 0.70 | TRIM24 (0.38) | MEN1CYP2C9KMT2A | |
| SCHEMBL992137 | 0.70 | — | — | |
| SCHEMBL9629481 | 0.70 | — | — | |
| SCHEMBL17995460 | 0.69 | TRIM24 (0.43) | MEN1CYP2C9KMT2A | |
| Ethylene SCHEMBL15565110 | 0.67 | TRIM24 (0.35) | MEN1CYP2C9KMT2A | |
| SCHEMBL11023410 | 0.65 | ALDH1A1 (0.30) | — | |
| SCHEMBL2002992 | 0.65 | ALDH1A1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230295068-A1 | NOVEL CYCLOALKENONE COMPOUND OR SALT THEREOF | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2023-09-21 | — | — | US | disclosed |
| EP-4194435-A1 | NOVEL CYCLOALKENONE COMPOUND OR SALT THEREOF | Taiho Pharmaceutical Co., Ltd. (JP) | 2023-06-14 | — | — | EP | disclosed |
| CN-116096361-A | Novel cyclic enone compound or salt thereof | 大鹏药品工业株式会社 | 2023-05-09 | — | — | CN | disclosed |
| US-9890139-B2 | CYP17 inhibitors/antiandrogens | ORION CORPORATION (FI) | 2018-02-13 | — | — | US | disclosed |
| US-20160130254-A1 | NOVEL CYP17 INHIBITORS/ANTIANDROGENS | ORION CORPORATION (FI) | 2016-05-12 | — | — | US | disclosed |
| EP-3008042-A1 | NOVEL CYP17 INHIBITORS/ANTIANDROGENS | Orion Corporation (FI) | 2016-04-20 | — | — | EP | disclosed |
| WO-2014202827-A1 | NOVEL CYP17 INHIBITORS/ANTIANDROGENS | ORION CORPORATION (FI) | 2014-12-24 | — | — | WO | disclosed |
| EP-1140845-B1 | SUSBSTITUTED PYRIDINE HERBICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2005-02-23 | — | — | EP | disclosed |
| US-6673938-B1 | Substituted pyridine herbicides | SYNGENTA PARTICIPATIONS AG (CH) | 2004-01-06 | — | — | US | disclosed |
| US-6534445-B1 | Pyridine ketones for controlling weeds | SYNGENTA PARTICIPATIONS AG (CH) | 2003-03-18 | — | — | US | disclosed |
| US-20030040437-A1 | Substituted pyridine herbicides | SYNGENTA PARTICIPATIONS AG (CH) | 2003-02-27 | — | — | US | disclosed |
| EP-1140845-A1 | SUSBSTITUTED PYRIDINE HERBICIDES | Syngenta Participations AG (CH) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000039094-A1 | SUBSTITUTED PYRIDINE HERBICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2000-07-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030040437-A1 | Substituted pyridine herbicides | DDT, CYP1A1, CYP1B1 | MEN1 2310/4885CYP2C9 84/4885KMT2A 1588/4885 |
| US-20160130254-A1 | NOVEL CYP17 INHIBITORS/ANTIANDROGENS | CYP17A1, CYP19A1, CYP21A2 | MEN1 1462/4885CYP2C9 84/4885KMT2A 650/4885 |
| US-20230295068-A1 | NOVEL CYCLOALKENONE COMPOUND OR SALT THEREOF | BDNF, SMN1; SMN2, ELAVL1 | MEN1 4376/4885CYP2C9 4187/4885KMT2A 3058/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.